Download PDF
1 / Pages

Other users also viewed these articles

Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease Juan Pablo Arab; Melisa Dirchwolf; Mário Reis Álvares-da-Silva; Francisco Barrera; Carlos Benítez; Marlene Castellanos-Fernandez; Graciela Castro-Narro; Norberto Chavez-Tapia; Daniela Chiodi; Helma Cotrim; Kenneth Cusi; Claudia Pinto Marques Souza de Oliveira; Javier Díaz; Eduardo Fassio; Solange Gerona; Marcos Girala; Nelia Hernandez; Sebastián Marciano; Walter Masson; Nahum Méndez-Sánchez; Nathalie Leite; Adelina Lozano; Martín Padilla; Arturo Panduro; Raymundo Paraná; Edison Parise; Marlene Perez; Jaime Poniachik; Juan Carlos Restrepo; Andrés Ruf; Marcelo Silva; Martín Tagle; Monica Tapias; Kenia Torres; Eduardo Vilar-Gomez; José Eduardo Costa Gil; Adrian Gadano; Marco Arrese;
Ann Hepatol. 2020;19:674-90
Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis Ankita Chatterjee; Analabha Basu; Kausik Das; Pankaj Singh; Dipankar Mondal; Biswanath Bhattacharya; Shweta Roychoudhury; Partha P. Majumder; Abhijit Chowdhury; Priyadarshi Basu;
Ann Hepatol. 2020;19:472-81
Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records Ignat Drozdov; Benjamin Szubert; Ian A. Rowe; Timothy J. Kendall; Jonathan A. Fallowfield;
10.1016/j.aohep.2024.101528